BALFX | FSANX | BALFX / FSANX | |
Total Expense Ratio | 0.61 | 0.64 | 95% |
Annual Report Gross Expense Ratio | 0.61 | 0.64 | 95% |
Fund Existence | 25 years | 18 years | - |
Gain YTD | 14.603 | 14.009 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 266B | 4.68B | 5,681% |
Annual Yield % from dividends | 1.72 | 1.85 | 93% |
Returns for 1 year | 8.67 | 10.87 | 80% |
Returns for 3 years | 50.44 | 44.83 | 113% |
Returns for 5 years | 41.92 | 37.41 | 112% |
Returns for 10 years | 75.26 | 79.00 | 95% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SWLVX | 15.92 | 0.08 | +0.51% |
Schwab ® US Large-Cap Value Index | |||
BRSUX | 15.25 | 0.02 | +0.13% |
MFS Blended Research Small Cap Eq R4 | |||
CIVIX | 24.34 | 0.02 | +0.08% |
Causeway International Value Instl | |||
HOMPX | 15.42 | -0.06 | -0.39% |
HW Opportunities MP | |||
GERAX | 11.18 | -0.05 | -0.45% |
Goldman Sachs Em Mkts Eq Insghts A |